Alerta De Seguridad para Cosman Medical Nitinol RF (TCN) Reusable Electrodes

Según Department of Health, este evento ( alerta de seguridad ) involucró a un dispositivo médico en Hong Kong que fue producido por Boston Scientific.

¿Qué es esto?

Las alertas proporcionan información importante y recomendaciones sobre los productos. Aunque se haya emitido una alerta, esto no significa necesariamente que el producto se considera peligroso. Las alertas de seguridad, dirigidas a trabajadores de la salud y a usuarios, pueden incluir retiro de equipos. Pueden ser escritas por los fabricantes, pero también por funcionarios del área de salud.

Más información acerca de la data acá
  • Tipo de evento
    Safety alert
  • Fecha
    2017-07-07
  • Fecha de publicación del evento
    2017-07-07
  • País del evento
  • Fuente del evento
    DH
  • URL de la fuente del evento
  • Notas / Alertas
    Hong Kong data is current through September 2018. All of the data comes from the Department of Health (Hong Kong), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Hong Kong.
  • Notas adicionales en la data
    Medical Device Safety Alert
  • Causa
    Medical device safety alert: boston scientific cosman medical nitinol rf (tcn) reusable electrodes medical device manufacturer, boston scientific, has issued a medical device safety alert concerning its cosman medical nitinol rf (tcn) reusable electrodes. the tcn electrodes were manufactured by cosman medical, a wholly-owned subsidiary of boston scientific, and affected units are labeled as cosman. the affected products are tcn-5, tcn-15-3m, tcnk-5-r, tcnk-15-c, tcn-5-3m, tcn-20, tcnk-10, tcnk-15-r, tcn-10, tcn-20-3m, tcnk-10-c, tcnk-20, tcn-10-3m, tcnk-5, tcnk-10-r, tcnk-20-c, tcn-15, tcnk-5-c, tcnk-15 and tcnk-20-r. according to the manufacturer, there have been complaints that after multiple reprocessing cycles, the epoxy resin which holds the tcn electrode in the hub can exhibit signs of damage. in some cases, this damage may result in the inability to fully remove blood and/or tissue residuals prior to cleaning and re-sterilizing the device. the failure to completely remove any blood and/or tissue from the tcn electrodes prior to re-sterilization creates a potential risk of infection and spread of blood borne pathogens to patients. the manufacturer has not received any reports of patient injury related to this issue. cosman stainless steel (csk) and disposable (tcd/cu/cur) electrodes are not affected by this action. the manufacturer advises users to take the following actions: if users have any of these affected electrodes within their inventory that have not been used, segregate the product immediately. unused/un-opened tcn electrodes should be identified as single use only (for one patient). these devices are supplied as non-sterile which require cleaning and sterilization prior to use. these tcn electrodes may be used once the cleaning and sterilization steps are completed. after single use, the used tcn electrode should be disposed of in accordance with their institution’s infectious material/biohazard waste control procedures. used tcn electrodes should be disposed immediately in accordance with their institution’s infectious material/biohazard waste control procedures. users should immediately discontinue use of devices that have already been used. according to the local supplier, the affected products are distributed in hong kong. if you are in possession of the affected products, please contact your supplier for necessary actions. posted on 7 july 2017.

Device

  • Modelo / Serial
  • Descripción del producto
    Medical Device Safety Alert: Boston Scientific Cosman Medical Nitinol RF (TCN) Reusable Electrodes
  • Manufacturer

Manufacturer

  • Empresa matriz del fabricante (2017)
  • Comentario del fabricante
    “We take a patient-first approach to assessing the applicability of every recall and communicate to regulatory bodies in all geographies where the recalled device is sold,” Boston Scientific said in a statement to ICIJ. “We have coordinated several recalls across many countries in a timely manner,” the company said, adding that it complies with all national laws, which can often vary and require different processes for reporting information or taking action on recalls. The company said it uses a rigorous and uniform process to take action on recalls and that “when we initiate a field action (e.g. recall, safety alert), every customer who has received an affected product receives a communication that includes a letter for the physician.”
  • Source
    DH